Patient Monitoring Devices are used to observe, measure, and record vital signs in patients. Exhalation Monitors use values such as breathing frequency, minute ventilation, and breathing effort to measure in the case of mild respiratory disorders. GlobalData uses proprietary data and analytics to provide a comprehensive report on the exhalation monitors devices market, including market shares of different players within Israel. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Israel Exhalation Monitors Market Share

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

In 2023, GlobalData’s Market Model methodology determined that the leading player in the exhalation monitors market in Israel was Koninklijke Philips followed by Dragerwerk, Vyaire Medical, Medtronic and Pulmonx.

Accurate monitoring and analysis of these values tend to early recognition and treatment of chronic respiratory failure.

The value of the exhalation monitors devices market within Israel was expected to be over $0.7m in 2023.

For the latest complete market share analysis of exhalation monitors device market in Israel, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.